Showing results (151-160 of 427) with videos related to

Sort By:
Pageof 43
Journal of the American College of Surgeons|January 17, 2017
Axillary Management of Stage II/III Breast Cancer in Patients Treated with Neoadjuvant Systemic Therapy: Results of CALGB 40601 (HER2-Positive) and CALGB 40603 (Triple-Negative)David W Ollila, Constance T Cirrincione, Donald A Berry, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2008
Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-upLee K Tan, Dilip Giri, Amanda J Hummer, et al.
Clinical Breast Cancer|February 6, 2010
Intravenous bisphosphonate therapy does not acutely alter nuclear bone scan resultsPatrick G Morris, Catherine Van Poznak, Shanu Modi, et al.
Seminars in Oncology|November 28, 1997
Dose-dense therapy with paclitaxel via weekly 1-hour infusion: preliminary experience in the treatment of metastatic breast cancerA D Seidman, C A Hudis, J McCaffrey, et al.
Journal of Bone Oncology|June 20, 2017
Assessing fracture risk in early stage breast cancer patients treated with aromatase-inhibitors: An enhanced screening approach incorporating trabecular bone scoreVeronica Mariotti, David B Page, Oksana Davydov, et al.
Trials|July 24, 2013
A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study): study protocol for a randomized controlled trialJosé Baselga, Frederico Costa, Henry Gomez, et al.
Breast Cancer Research and Treatment|December 9, 2016
Estimating the OncotypeDX score: validation of an inexpensive estimation toolAnne A Eaton, Catherine E Pesce, James O Murphy, et al.
Molecular Oncology|August 25, 2014
Serum metabolomic profiles evaluated after surgery may identify patients with oestrogen receptor negative early breast cancer at increased risk of disease recurrence. Results from a retrospective studyLeonardo Tenori, Catherine Oakman, Patrick G Morris, et al.
AJR. American Journal of Roentgenology|November 30, 1999
Complete percutaneous excision of infiltrating carcinoma at stereotactic breast biopsy: how can tumor size be assessed?L Liberman, M F Zakowski, S Avery, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 15, 2015
Appearance of untreated bone metastases from breast cancer on FDG PET/CT: importance of histologic subtypeBrittany Z Dashevsky, Debra A Goldman, Molly Parsons, et al.
Pageof 43